RenalytixAI (RENX.L): Proposed dual-listing on Nasdaq | e-therapeutics (ETX.L): Covid-19 project update | RedX (REDX.L): Appointment of Non-Executive Director
18 May 2020
SP Angel Healthcare Conditions
Renalytix Plc (RENX:LON), 26.5 | e-Therapeutics plc (ETX:LON), 9.2 | Redx Pharma Plc (REDX:LON), 10.2
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
Renalytix Plc (RENX:LON), 26.5 | e-Therapeutics plc (ETX:LON), 9.2 | Redx Pharma Plc (REDX:LON), 10.2
- Published:
18 May 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
RenalytixAI (RENX.L): Proposed dual-listing on Nasdaq | e-therapeutics (ETX.L): Covid-19 project update | RedX (REDX.L): Appointment of Non-Executive Director